HIT Consultant December 9, 2024
Syed Hamza Sohail

What You Should Know:

Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.

– The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.

Carta Healthcare and Realyze Intelligence: Transforming Clinical Data Management with AI-Powered Solutions

Carta Healthcare and Realyze Intelligence are revolutionizing healthcare data abstraction and analysis by leveraging artificial intelligence (AI) to address inefficiencies and improve patient outcomes. Their advanced platforms combine clinician expertise with AI-driven automation to provide faster, cost-effective, and high-quality insights into clinical data for oncology...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Mergers & Acquisitions / JV, Technology, Trends
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape
Generative AI has ‘potential to revolutionise clinical development’
Treating Covid burnout with ’shrooms

Share This Article